News

  For patients with uveal melanoma, the most common eye cancer in adults, survival outcomes have improved in recent years, after treatment modalities shifted from systemic to liver-directed therapies. The finding comes from researchers at the Thomas Jefferson University in Philadelphia, Pennsylvania, and was presented at the recent American Society of Clinical Oncology (ASCO) 2018… Read More »Uveal Melanoma: Better Survival With Liver Directed Therapy.

Author: Nick Mulcahy The U.S. Food and Drug Administration has approved the first biosimilar to pegfilgrastim (Neulasta, Amgen), a granulocyte colony-stimulating factor used to reduce infection risk in patients with cancer. The new product is pegfilgrastim-jmdb ( Fulphila , Mylan GmbH), approved for use to decrease the risk for infection in patients with nonmyeloid cancer who are receiving… Read More »FDA Approves Pegfilgrastim Biosimilar for Cancer Infection Risk

Patients with cancer are at a high risk for “financial toxicity,” and nurses need to be equipped to talk to them about the financial aspects of their care, according to Teresa Hagan Thomas, PhD, RN, from the University of Pittsburgh School of Nursing. It is not only the cost of treatment that contributes to financial… Read More »Financial Stress A Key Factor In Cancer Patient Care Plan.

India’s Trusted Pharmacy: Purchase Cancer Drugs Online in India No more running from one chemist store to another when in need of medicines! GDMeds.com brings to you an online medicine store, which can be accessed for all health needs. We are focused towards making healthcare accessible and affordable, especially for cancer drugs, such as chemotherapy,… Read More »GDMeds.com explore a new way to serve the people

Is eating eggs bad for your heart due to their high cholesterol content? You may make mistake, please think again. A large research has now shown that people who eat an egg every day could significantly reduce their risk of cardiovascular diseases. What an interesting thing. “The present study finds that there is an association between… Read More »New Research: An Egg A Day Keep Heart Attack Away

Author: Mark G. Kris, MD Hello. This is Mark Kris from Memorial Sloan Kettering. I am speaking to you today about three papers that appeared in JAMA Oncology on January 11, 2018, dealing with the adverse effects of immune checkpoint inhibitors. There was a commentary and two papers. My issue with these presentations is the lack of discussion of benefits… Read More »‘Oncology Done Right Is About Balance’: Weighing Immunotherapy Side Effects

Reporter: Megan Brook The European Medicines Agency (EMA) is reviewing the risk of dosing errors with medicines containing methotrexate. The review is based on “continued reports of overdose,” the agency announced today. Methotrexate is used to treat various inflammatory conditions, such as arthritis, psoriasis, and some cancers, such as acute lymphoblastic leukemia. Methotrexate can be taken… Read More »Risk of Methotrexate Dosing Errors Prompts EMA Review

Colorectal cancer refers to cancer that starts in the colon or rectum. It is the most common type of cancer that affects people over the age of 60 years. The three main symptoms of colorectal cancer are: Persistent blood in the stools – occurs for no obvious reasons and associated with a change in the… Read More »Colorectal cancer: What are the causes, symptoms and treatment

Reporter: Zosia Chustecka A new option for the treatment of ovarian cancer could soon be available in Europe: the PARP (poly [adenosine diphosphate-ribose] polymerase) inhibitor rucaparib (Rubraca, Clovis). At its latest meeting the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA) recommended a conditional marketing authorization for rucaparib… Read More »Rucaparib for Ovarian Cancer OK’d for Approval in Europe

Author: Betty R. Ferrell, PhD, RN Tired of Treatment Paulo is a 49-year-old man with a recurrent brain tumor; he is now hospitalized after experiencing seizures. The tumor was diagnosed when Paulo was 44 years of age, and he has had extensive surgery, chemotherapy, and radiation therapy. Three months ago, the brain tumor team advised Paulo… Read More »Clinicians as Communication Coaches – Preparing Patients for Difficult Conversations

Smoking is one of the main causes of preventable deaths throughout the world. When smoke enters the human body it affects nearly each and every organ leading to many life-threatening diseases. The poisons from the cigarette, which are basically tar and other chemicals when entering the bloodstream, are responsible for narrowing the arteries as well as… Read More »How smoking ruins your lungs

Author: David J. Kerr, CBE, MD, DSc, FRCP, FMedSci Hi. I’m David Kerr, professor of cancer medicine from the University of Oxford. As you know, I’ve believed for some time that ploidy (the number of sets of chromosomes in a cell) measurements have been largely overlooked in terms of the relative importance of prognostic markers for… Read More »Overlooked Biomarker May Predict Cancer Immunotherapy Response